Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X CleanTech (CTEC) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Global X CleanTechTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Global X CleanTech vs Zimmer Biomet Holdings Inc — how do they compare? Global X CleanTech trades at $58.44, while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.65B). The key difference: Zimmer Biomet Holdings Inc pays a 0.98% dividend while Global X CleanTech pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, Global X CleanTech nearer its low. Which is the better fit depends on your goals.

CTECZBH
Sector
Sector/ThematicHealth
52-Week High
$78.11$107.71
52-Week Low
$41.08$79.58
Market Cap
$18.65B
Enterprise Value
$25.72B
Dividend Yield
0.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X CleanTech

CTEC trades at $58.40, up 2.1% today, with a neutral technical signal overall. Moving averages suggest a bullish trend, while oscillators are neutral. The stock faces resistance near $60 and support at $53. A dividend of $0.07 is scheduled for July 2026. Key financial ratios are currently unavailable.

The outlook hinges on upcoming financial disclosures to assess fundamentals. Near-term price action may test resistance at $60. Risks include lack of recent financial data and market volatility. Investor sentiment appears balanced pending further company updates.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $96.55, down 0.66% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.07, and raised its full-year outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology, though net income margin has moderated from 2023 peaks. Recent corporate news includes a dividend declaration and expansion of its technology center in India.

The outlook for ZBH is positive, driven by consistent earnings beats and strategic growth initiatives, but investors face risks from margin pressure and increasing debt levels. The stock offers potential upside to the consensus target, supported by institutional accumulation, though competitive and macroeconomic headwinds in the medtech sector warrant caution.

Returns comparison

Trailing returns across standard periods

About Global X CleanTech

CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.

Read more on CTEC

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH